互联网+新型药学服务模式在医院儿童反复哮喘管理中的实践与效果分析  

Practice and effect analysis of internet+new pharmaceutical care mode in the management of recurrent asthma in hospital children

作　　者：陈远佳 苏李慧 王伏英 CHEN Yuanjia;SU Lihui;WANG Fuying(Shangrao Maternal and Child Health Hospital,Shangrao 334000,China)

机构地区：[1]上饶市妇幼保健院,江西上饶334000

出　　处：《临床医药实践》2024年第11期843-845,851,共4页Proceeding of Clinical Medicine

基　　金：上饶市指导性科技计划项目(项目编号:2023CZDX48)。

摘　　要：目的:分析互联网+新型药学服务模式在医院儿童反复哮喘管理中的实践与效果。方法:回顾性分析2021年7月—2023年6月收治的106例反复哮喘儿童的临床资料,根据入院时间分为对照组(常规药学服务模式)和观察组(互联网+新型药学服务模式),每组53例,干预6个月。比较两组治疗周期及干预前后哮喘控制测试(C-ACT)、Morisky用药依从性量表(MMAS-8)和自制哮喘疾病知识问卷评分以及不良反应发生和哮喘复发情况。结果:干预前,两组C-ACT,MMAS-8和哮喘疾病知识问卷评分比较,差异无统计学意义(P>0.05)。干预后,观察组治疗周期短于对照组,C-ACT,MMAS-8和哮喘疾病知识问卷评分高于对照组,差异有统计学意义(P<0.05)。干预期间,观察组不良反应发生率和哮喘复发率均低于对照组,差异有统计学意义(P<0.05)。结论:互联网+新型药学服务模式可有效控制病情发展,提升患儿家属对疾病的认识程度,积极预防儿童反复哮喘发作。Objective:To analyze the practice and effect of internet+new pharmaceutical care mode in the management of recurrent asthma in hospital children.Methods:A retrospective analysis was performed on the clinical data of 106 children with recurrent asthma in the hospital between July 2021 and June 2023.According to the time of admission,they were divided into control group(routine pharmaceutical care mode)and study group(internet+new pharmaceutical care mode),53 cases in each group.All children were intervened for 6 months.The treatment cycle,scores of children-asthma control test(C-ACT),morisky medication adherence scale(MMAS-8)and self-made asthma disease knowledge questionnaire before and after intervention,occurrence of adverse reactions and asthma recurrence during intervention were compared between the two groups.Results:Before intervention,the scores of C-ACT,MMAS-8 and asthma knowledge questionnaire had no significant difference between the two groups(P>0.05).After intervention,treatment cyclewas shorter,and scores of C-ACT,MMAS-8 and asthma disease knowledge questionnaire were higher in study group(P<0.05).During intervention,the incidence of adverse reactions in study group was lower than that in control group,and recurrence rate of asthma was also lower than that in control group(P<0.05).Conclusion:Internet+new pharmaceutical care mode can effectively control diseasedevelopment in children,improve disease cognition of family members and actively prevent recurrence asthma.

关 键 词：互联网+ 药学服务 儿童 哮喘 

分 类 号：R725.6[医药卫生—儿科]